Moors & Cabot’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,450
| Closed | -$284K | – | 875 |
|
|
2024
Q2 | $284K | Sell |
3,450
-20
| -0.6% | -$1.65K | 0.02% | 644 |
|
|
2024
Q1 | $303K | Buy |
3,470
+482
| +16% | +$42.1K | 0.02% | 665 |
|
|
2023
Q4 | $288K | Buy |
2,988
+22
| +0.7% | +$2.12K | 0.02% | 636 |
|
|
2023
Q3 | $262K | Sell |
2,966
-1,298
| -30% | -$115K | 0.02% | 638 |
|
|
2023
Q2 | $370K | Sell |
4,264
-199
| -4% | -$17.2K | 0.02% | 540 |
|
|
2023
Q1 | $434K | Buy |
4,463
+33
| +0.7% | +$3.21K | 0.03% | 477 |
|
|
2022
Q4 | $458K | Sell |
4,430
-37
| -0.8% | -$3.83K | 0.03% | 452 |
|
|
2022
Q3 | $379K | Sell |
4,467
-1,305
| -23% | -$111K | 0.03% | 483 |
|
|
2022
Q2 | $478K | Hold |
5,772
| – | – | 0.03% | 427 |
|
|
2022
Q1 | $445K | Sell |
5,772
-63
| -1% | -$4.86K | 0.03% | 501 |
|
|
2021
Q4 | $516K | Buy |
5,835
+1,200
| +26% | +$106K | 0.03% | 453 |
|
|
2021
Q3 | $357K | Buy |
4,635
+205
| +5% | +$15.8K | 0.02% | 541 |
|
|
2021
Q2 | $370K | Buy |
+4,430
| New | +$370K | 0.03% | 504 |
|
|
2015
Q2 | – | Sell |
-2,158
| Closed | -$266K | – | 526 |
|
|
2015
Q1 | $266K | Buy |
+2,158
| New | +$266K | 0.04% | 408 |
|